found that NLRP3 inflammasome activation and significantly elevated IL-18 levels in DLBCL tissues promoted CD8+ T cell apoptosis by up-regulating programmed death ligand-1 (PD-L1), thereby exerting immunosuppressive effects (142). This evidence concerns the gene NLRP3 and diffuse large B-cell lymphoma.